Page last updated: 2024-09-05

sb 203580 and allopurinol

sb 203580 has been researched along with allopurinol in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(allopurinol)
Trials
(allopurinol)
Recent Studies (post-2010) (allopurinol)
3,48941,13715,0967433,363

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)allopurinol (IC50)
Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase Rattus norvegicus (Norway rat)3.3765
Xanthine dehydrogenase/oxidaseHomo sapiens (human)3.1861
Xanthine dehydrogenase/oxidaseBos taurus (cattle)5.0758
Histamine H3 receptorCavia porcellus (domestic guinea pig)8.69

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bucio, L; Escobar, Mdel C; Gómez-Quiroz, LE; Gutiérrez Ruiz, MC; Hernández, E; Souza, V1

Other Studies

1 other study(ies) available for sb 203580 and allopurinol

ArticleYear
NADPH oxidase and ERK1/2 are involved in cadmium induced-STAT3 activation in HepG2 cells.
    Toxicology letters, 2009, Jun-22, Volume: 187, Issue:3

    Topics: Allopurinol; Anthracenes; Blotting, Western; Cadmium; Electrophoretic Mobility Shift Assay; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Humans; Imidazoles; Liver; NADPH Oxidases; Onium Compounds; Phosphorylation; Potassium Cyanide; Pyridines; Signal Transduction; STAT3 Transcription Factor; Sulfones

2009